FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004332616> ?p ?o ?g. }

• W2004332616 endingPage "735" @default.
• W2004332616 startingPage "728" @default.
• W2004332616 abstract "Background/Aims Gene therapy might be a promising therapeutic approach for advanced hepatocellular carcinoma (HCC) not amenable to any effective traditional treatment. The aim of the study was to evaluate the in vitro and in vivo efficacy of combined gene therapy of HCC with two different MoMLV-derived retroviral vectors, an MFG- and a LXSN-derived vector, both containing HSV-TK and hIL-2. Results In vitro experiments on HCC cells showed efficient killing of transduced cells and efficient bystander effect after ganciclovir (GCV) treatment, with higher antitumor activity when the MFG-based vector was used. In vivo studies in a murine syngenic model of HCC demonstrated that treatment with GCV led to complete regression of tumors composed of transduced cells and regression of distant non-transduced tumors. Tumor transduction and efficacy of treatment was also demonstrated after in vivo delivery of vectors. Microarray analysis of tumor samples in mice receiving gene therapy showed up-regulation of genes involved in immune response and signal transduction. Conclusions We demonstrated the in vitro and in vivo efficacy of combined retroviral-mediated gene therapy for HCC, with significant systemic therapeutic efficacy in vivo. Gene therapy might be a promising therapeutic approach for advanced hepatocellular carcinoma (HCC) not amenable to any effective traditional treatment. The aim of the study was to evaluate the in vitro and in vivo efficacy of combined gene therapy of HCC with two different MoMLV-derived retroviral vectors, an MFG- and a LXSN-derived vector, both containing HSV-TK and hIL-2. In vitro experiments on HCC cells showed efficient killing of transduced cells and efficient bystander effect after ganciclovir (GCV) treatment, with higher antitumor activity when the MFG-based vector was used. In vivo studies in a murine syngenic model of HCC demonstrated that treatment with GCV led to complete regression of tumors composed of transduced cells and regression of distant non-transduced tumors. Tumor transduction and efficacy of treatment was also demonstrated after in vivo delivery of vectors. Microarray analysis of tumor samples in mice receiving gene therapy showed up-regulation of genes involved in immune response and signal transduction. We demonstrated the in vitro and in vivo efficacy of combined retroviral-mediated gene therapy for HCC, with significant systemic therapeutic efficacy in vivo." @default.
• W2004332616 created "2016-06-24" @default.
• W2004332616 creator A5000973050 @default.
• W2004332616 creator A5015771184 @default.
• W2004332616 creator A5048101829 @default.
• W2004332616 creator A5052909381 @default.
• W2004332616 creator A5054179969 @default.
• W2004332616 creator A5068279912 @default.
• W2004332616 creator A5083698836 @default.
• W2004332616 creator A5091348755 @default.
• W2004332616 date "2005-05-01" @default.
• W2004332616 modified "2023-10-16" @default.
• W2004332616 title "Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma" @default.
• W2004332616 cites W1584574750 @default.
• W2004332616 cites W1977039120 @default.
• W2004332616 cites W1999369189 @default.
• W2004332616 cites W2020215421 @default.
• W2004332616 cites W2040923398 @default.
• W2004332616 cites W2047636094 @default.
• W2004332616 cites W2063993429 @default.
• W2004332616 cites W2065533784 @default.
• W2004332616 cites W2076410383 @default.
• W2004332616 cites W2078280873 @default.
• W2004332616 cites W2093033362 @default.
• W2004332616 cites W2115565361 @default.
• W2004332616 cites W2115921134 @default.
• W2004332616 cites W2317676617 @default.
• W2004332616 cites W2320304105 @default.
• W2004332616 cites W2322448202 @default.
• W2004332616 cites W2330018753 @default.
• W2004332616 cites W4211107801 @default.
• W2004332616 cites W4211228022 @default.
• W2004332616 cites W4234699444 @default.
• W2004332616 cites W4243403540 @default.
• W2004332616 cites W4245721392 @default.
• W2004332616 doi "https://doi.org/10.1016/j.jhep.2004.12.037" @default.
• W2004332616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15826723" @default.
• W2004332616 hasPublicationYear "2005" @default.
• W2004332616 type Work @default.
• W2004332616 sameAs 2004332616 @default.
• W2004332616 citedByCount "33" @default.
• W2004332616 countsByYear W20043326162013 @default.
• W2004332616 countsByYear W20043326162014 @default.
• W2004332616 crossrefType "journal-article" @default.
• W2004332616 hasAuthorship W2004332616A5000973050 @default.
• W2004332616 hasAuthorship W2004332616A5015771184 @default.
• W2004332616 hasAuthorship W2004332616A5048101829 @default.
• W2004332616 hasAuthorship W2004332616A5052909381 @default.
• W2004332616 hasAuthorship W2004332616A5054179969 @default.
• W2004332616 hasAuthorship W2004332616A5068279912 @default.
• W2004332616 hasAuthorship W2004332616A5083698836 @default.
• W2004332616 hasAuthorship W2004332616A5091348755 @default.
• W2004332616 hasConcept C104317684 @default.
• W2004332616 hasConcept C111599444 @default.
• W2004332616 hasConcept C135983454 @default.
• W2004332616 hasConcept C150903083 @default.
• W2004332616 hasConcept C15152581 @default.
• W2004332616 hasConcept C19106626 @default.
• W2004332616 hasConcept C202751555 @default.
• W2004332616 hasConcept C203014093 @default.
• W2004332616 hasConcept C207001950 @default.
• W2004332616 hasConcept C2522874641 @default.
• W2004332616 hasConcept C2777965375 @default.
• W2004332616 hasConcept C2778019345 @default.
• W2004332616 hasConcept C2779820661 @default.
• W2004332616 hasConcept C32470452 @default.
• W2004332616 hasConcept C34981463 @default.
• W2004332616 hasConcept C40767141 @default.
• W2004332616 hasConcept C502942594 @default.
• W2004332616 hasConcept C55493867 @default.
• W2004332616 hasConcept C71924100 @default.
• W2004332616 hasConcept C86803240 @default.
• W2004332616 hasConceptScore W2004332616C104317684 @default.
• W2004332616 hasConceptScore W2004332616C111599444 @default.
• W2004332616 hasConceptScore W2004332616C135983454 @default.
• W2004332616 hasConceptScore W2004332616C150903083 @default.
• W2004332616 hasConceptScore W2004332616C15152581 @default.
• W2004332616 hasConceptScore W2004332616C19106626 @default.
• W2004332616 hasConceptScore W2004332616C202751555 @default.
• W2004332616 hasConceptScore W2004332616C203014093 @default.
• W2004332616 hasConceptScore W2004332616C207001950 @default.
• W2004332616 hasConceptScore W2004332616C2522874641 @default.
• W2004332616 hasConceptScore W2004332616C2777965375 @default.
• W2004332616 hasConceptScore W2004332616C2778019345 @default.
• W2004332616 hasConceptScore W2004332616C2779820661 @default.
• W2004332616 hasConceptScore W2004332616C32470452 @default.
• W2004332616 hasConceptScore W2004332616C34981463 @default.
• W2004332616 hasConceptScore W2004332616C40767141 @default.
• W2004332616 hasConceptScore W2004332616C502942594 @default.
• W2004332616 hasConceptScore W2004332616C55493867 @default.
• W2004332616 hasConceptScore W2004332616C71924100 @default.
• W2004332616 hasConceptScore W2004332616C86803240 @default.
• W2004332616 hasIssue "5" @default.
• W2004332616 hasLocation W20043326161 @default.
• W2004332616 hasLocation W20043326162 @default.
• W2004332616 hasOpenAccess W2004332616 @default.
• W2004332616 hasPrimaryLocation W20043326161 @default.
• W2004332616 hasRelatedWork W1963729009 @default.

• next